For the quarter ended December 2025, Labcorp Holdings (LH) reported revenue of $3.52 billion, up 5.6% over the same period last year. EPS came in at $4.07, compared to $3.45 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $3.55 billion, representing a surprise of -0.97%. The company delivered an EPS surprise of +2.98%, with the consensus EPS estimate being $3.95.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Labcorp performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net book-to-bill Ratio ( TTM Book-to-Bill): 1.1% compared to the 1.1% average estimate based on two analysts.
- Revenues- Biopharma Laboratory Services: $793 million compared to the $791.05 million average estimate based on four analysts. The reported number represents a change of +3.4% year over year.
- Revenues- Diagnostics Laboratories: $2.73 billion compared to the $2.77 billion average estimate based on four analysts. The reported number represents a change of +5.5% year over year.
- Adjusted Operating Income- Diagnostics Laboratories: $419.2 million versus the three-analyst average estimate of $423.58 million.
- Adjusted Operating Income- Biopharma Laboratory Services: $136.1 million compared to the $130.1 million average estimate based on three analysts.
- Adjusted Operating Income- Unallocated corporate expense: $-67.6 million compared to the $-69.13 million average estimate based on two analysts.
View all Key Company Metrics for Labcorp here>>>
Shares of Labcorp have returned +4.3% over the past month versus the Zacks S&P 500 composite's -1.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Labcorp Holdings Inc. (LH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
